Protective and therapeutic effects of resveratrol on acetic acid-induced gastric ulcer

Free Radical Research

Volumn 43, Issue 6, 2009, Pages 594-603

  Solmaz, Ali ^a   Şener, Göksel ^a   Çetinel, Şule ^a   Yüksel, Meral ^a   Yeǧen, Cumhur ^a   Yeǧen, Berrak Ç ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Oxidative stress; Resveratrol; Ulcer healing

Indexed keywords

COLLAGEN; LUCIGENIN; LUMINOL; MALONALDEHYDE; MYELOPEROXIDASE; OXYGEN RADICAL; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL RENEWAL; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEPLETION; RAT; SCORING SYSTEM; STOMACH CONTENT; STOMACH ULCER; TREATMENT RESPONSE;

ACETIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; FEMALE; GLUTATHIONE; IRRITANTS; LIPID PEROXIDATION; LUMINESCENCE; MALE; MALONDIALDEHYDE; NEUTROPHILS; OXIDATIVE STRESS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; STOMACH ULCER;

RATTUS;

EID: 67651024748     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760902977424     Document Type: Article

References (59)

1. Eastwood GL. Is smoking still important in the pathogenesis of peptic ulcer disease? J Clin Gastroenterol 1997;25 (Suppl 1):S1-S7.
2. Tarnawski AS. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 2005;50(Suppl 1): S24-S33.
3. Taupin D, Wu D-C, Jeon W-K, Devaney K, Wang TC, Podolsky DK. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor-and MAP kinase-dependent interregulation. J Clin Invest 1990;103:R31-R38.
4. Wong WM, Playford RJ, Wright NA. Peptide gene expression in gastrointestinal mucosal ulceration: Ordered sequence or redundancy? Gut 2000;46:286-292.
5. Günal O, Oktar BK, Ozçinar E, Sungur M, Arbak S, Yeǧen B. Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats. Inflammation 2003;27:351-359.
6. Okabe S, Amagase K. An overview of acetic acid ulcer models - the history and state of the art of peptic ulcer research. Biol Pharm Bull 2005;28:1321-1341.
7. Soleas GJ, Diamandis EP, Goldberg DM. The world of resveratrol. Adv Exp Med Biol 2001;492:159-182.
8. Holme AL, Pervaiz S. Resveratrol in cell fate decisions. J Bioenerg Biomembr 2007;39:59-63.
9. Pirola L, Fröjdö S. Resveratrol: One molecule, many targets. IUBMB Life 2008;60:323-332.
10. Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 2007;18:567-579.
11. Giovannini C, Filesi C, D'Archivio M, Scazzocchio B, Santangelo C, Masella R. Polyphenols and endogenous antioxidant defences: Effects on glutathione and glutathione related enzymes. Ann Ist Super Sanita 2006;42:336-347.
12. Kolgazi M, Sener G, Cetinel S, Gedik N, Alican I. Resveratrol reduces renal and lung injury caused by sepsis in rats. J Surg Res 2006;134:315-321.
13. Sener G, Toklu HZ, Sehirli AO, Velioglu-Ogünç A, Cetinel S, Gedik N. Protective effects of resveratrol against acetaminophen- induced toxicity in mice. Hepatol Res 2006;35:62-68.
14. Sener G, Tuǧtepe H, Yüksel M, Cetinel S, Gedik N, Yeǧen BC. Resveratrol improves ischemia/reperfusioninduced oxidative renal injury in rats. Arch Med Res 2006; 37:822-829.
15. Toklu H, Alican I, Ercan F, Sener G. The beneficial effect of resveratrol on rat bladder contractility and oxidant damage following ischemia/reperfusion. Pharmacology 2006;78: 44-50.
16. Sehirli O, Sakarcan A, Velioǧlu-Oǧünç A, Cetinel S, Gedik N, Yeǧen BC, et al. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats. Toxicol Appl Pharmacol 2007; 222:33-41.
17. Sener G, Topaloǧlu N, Sehirli AO, Ercan F, Gedik N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm Pharmacol Ther 2007;20:642-649.
18. Sehirli O, Tozan A, Omurtag GZ, Cetinel S, Contuk G, Gedik N, et al. Protective effect of resveratrol against naphthalene-induced oxidative stress in mice. Ecotoxicol Environ Saf 2008;71:301-308.
19. Tatlidede E, Sehirli O, Velioǧlu-Oǧunc A, Cetinel S, Yeǧen BC, Yarat A, et al. Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage. Free Radic Res 2009;43:195-205.
20. Kirimlioglu V, Ara C, Yilmaz M, Ozgor D, Isik B, Sogutlu G, et al. Resveratrol, a red wine constituent polyphenol, protects gastric tissue against the oxidative stress in cholestatic rats. Dig Dis Sci 2006;51:298-302.
21. Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, Stachura J, et al. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions. Eur J Pharmacol 1999;385:47-61.
22. Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Pajdo R, Drozdowicz D, et al. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc Res Tech 2001;53:343-353.
23. Okabe S, Pfeiffer CJ. Chronicity of acetic acid ulcer in the rat stomach. Am J Dig Dis 1972;17:619-629.
24. Okabe S, Roth JL, Pfeiffer CJ. A method for experimental, penetrating gastric and duodenal ulcers in rats. Observations on normal healing. Am J Dig Dis 1971;16:277-284.
25. Beuge JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
26. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-888.
27. Bradley PP, Priebat DA, Christersen RD, Rothstein G. Measurement of cutaneous inflammation. Estimation of neutrophil content with an enzyme marker. J Invest Dermato 1982;78:206-209
28. Hillegass LM, Griswold DE, Brickson B, Albrightson-Winslow C. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 1990;24:285-295.
29. Ohara Y, Peterson TE, Harrisorn DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;92:2546-2551.
30. Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Laurenson IF, Blake DR, Rampton DS. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-185.
31. Haklar G, Özveri ES, Yüksel M, Aktan AÖ, Yalçin AS. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 2001; 165:219-224.
32. Lopez De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalinfixed parraffin-embedded sections. J Histochem Cytochem 1985;33:737-743.
33. Yoshikawa T, Naito Y, Ueda S, Oyamada H, Takemura T, Yoshida N, Sugino S, Kondo M. Role of oxygen-derived free radicals in the pathogenesis of gastric mucosal lesions in rats. J Clin Gastroenterol 1990;12(Suppl 1):S65-S71.
34. Naito Y, Yoshikawa T, Matsuyama K, Yagi N, Arai M, Nakamura Y, et al. Effects of oxygen radical scavengers on the quality of gastric ulcer healing in rats. J Clin Gastroenterol 1995;(Suppl 1):S82-S86.
35. Banerjee D, Bhattacharya S, Bandyopadhyay SK, Chattopadhyay S. Biochemical mechanism of healing activity of the natural phenolic, allylpyrocatechol against indomethacin-induced gastric ulceration in mice. Dig Dis Sci 2008;53:2868-2877.
36. Opie LH, Lecour S. The red wine hypothesis: From concepts to protective signalling molecules. Eur Heart J 2007; 28:1683-1693.
37. de Almeida LM, Leite MC, Thomazi AP, Battu C, Nardin P, Tortorelli LS, et al. Resveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats. Arch Biochem Biophys 2008;480: 27-32.
38. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 2006;5:493-506.
39. Kirimlioglu V, Ara C, Yilmaz M, Ozgor D, Isik B, Sogutlu G, et al. Resveratrol, a red wine constituent polyphenol, protects gastric tissue against the oxidative stress in cholestatic rats. Dig Dis Sci 2006;51:298-302.
40. Guo JS, Cho CH, Wang JY, Koo MW. Differential effects of selective and non-selective inhibition of nitric oxide synthase on the expression and activity of cyclooxygenase-2 during gastric ulcer healing. Eur J Pharmacol 2006;536:301-308.
41. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002;106:1652-1658.
42. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, de Gaetano G, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol 1998;123:1691-1699.
43. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
44. Olas B, Zbikowska HM, Wachowicz B, Krajewski T, Buczyński A, Magnuszewska A. Inhibitory effect of resveratrol on free radical generation in blood platelets. Acta Biochim Pol 1999;46:961-966.
45. Tadolini B, Juliano C, Piu L, Franconi F, Cabrini L. Resveratrol inhibition of lipid peroxidation. Free Radic Res 2000;33:105-114.
46. Iseri SÖ, Sener G, Saglam B, Gedik N, Ercan F, Yegen BÇ. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides 2005;26:483-491.
47. Ross D. Glutathione, free radicals and chemotherapeutic agents. Pharmacol Ther 1988;37:231-249.
48. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 2009;1250:242-253.
49. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, et al. Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 2008;15:1545-1551.
50. Souza MH, Lemos HP, Oliveira RB, Cunha FQ. Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut 2004;53: 791-796.
51. Holzer P. Gastroduodenal mucosal defense: Coordination by a network of messengers and mediators. Curr Opin Gastroenterol 2001;17:489-496.
52. Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: A master-regulator of leukocyte movement. Immunol Today 2000;21:110-113.
53. Martinez J, Moreno JJ. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem Pharmacol 2000;59: 865-870.
54. Leiro J, Arranz JA, Fraiz N, Sanmartin ML, Quezada E, Orallo F. Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling. Int Immunopharmacol 2005;5: 393-406.
55. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, et al. Resveratrol scavenges reactive oxygen species and effects radicalinduced cellular responses. Biochem Biophys Res Commun 2003;309:1017-1026.
56. Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG. Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol. Am J Physiol Heart Circ Physiol 2005;288:H1131-H1138.
57. Uguralp S, Irsi C, Aksoy T, Karabulut AB, Kirimlioglu H, Mizrak B. Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns. Pediatr Surg Int 2008;24:425-430.
58. Souza IC, Martins LA, Coelho BP, Grivicich I, Guaragna RM, Gottfried C, Borojevic R, Guma FC. Resveratrol inhibits cell growth by inducing cell cycle arrest in activated hepatic stellate cells. Mol Cell Biochem 2008;315:1-7.
59. Hashem MA, Jun KY, Lee E, Lim S, Park Choo HY, Kwon Y. A Rapid and sensitive screening system for human type I collagen with the aim of discovering potent anti-aging or anti-fibrotic compounds. Mol Cells 2008;26:6.